Hermiller, James B <br/><br/>
Sustained low clinical event rates in real-world patients receiving everolimus-eluting coronary stent system from a large, prospective, condition of approval study: 2-year clinical outcomes from the XIENCE V USA Study.  [electronic resource] 

 -  Journal of interventional cardiology  Dec 2012 
 - 565-75 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1540-8183 
<br/><br/><label>Standard No.: </label>10.1111/j.1540-8183.2012.00766.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angioplasty, Balloon, Coronary<br/>Cardiovascular Agents--administration & dosage<br/>Coronary Artery Disease--therapy<br/>Drug-Eluting Stents<br/>Everolimus<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Myocardial Infarction--epidemiology<br/>Prospective Studies<br/>Sirolimus--administration & dosage<br/>Thrombosis--epidemiology<br/>United States--epidemiology